Investors Are Buzzing About These 5 Morning Movers
In contrast to yesterday's action, the major indexes are all green today, with crude futures leading the way, up by 5%.
Intercept Pharmaceuticals Inc. (ICPT)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Why Are These Stocks Among Today's Losers?
This week's roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate Corporation (NYSE:IRC...
Is Intercept Pharmaceuticals Inc (ICPT) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...
These Five Biotech Stocks Ranked Among This UK-based Fund's Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed's Recent Activity in Biotech
Stocks in the biotechnology industry have been very active as of late, with companies' shares registering significant gains.
Healthcare Hedge Fund Orbimed's Top Picks and New Move
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay's Orbimed Advisors has slashed its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT) by about...
Applied Genetic Technologies Corp (AGTC): Steve Cohen Starts New Stake With 5.8% of The Company’s Outstanding Stock
Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with Mr.
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission.
Orbimed Advisors Further Cuts Exposure To Intercept Pharmaceuticals Inc. (ICPT)
Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT).
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
